Table 1. NAD+ levels are reduced by SD and oxidant exposures, and are restored by pyruvate, nicotinamide, and TPEN.
Condition | NAD+ (nmols/mg) | FBP (nmols/mg) |
---|---|---|
Control | 2.9 ± 0.2 | 4.0 ± 0.3 |
+ Zn2+ preload | 2.76 ± 0.2 | N.P. |
30 µM Ethacrynic acid (2 hr) | 1.69 ± 0.15 * | 11.3 ± 0.5 * |
+ 10 mM pyruvate | 2.27 ± 0.13 # | 5.1 ± 0.3 # |
+ 10 mM nicotinamide | 2.35 ± 0.13 # | 5.3 ± 0.4 # |
+ Zn2+ preload | 0.29 ± 0.03 # | N.P. |
80 µM H2O2 (2 hr) | 0.69 ± 0.03 * | 14.3 ± 0.6 * |
+ 10 mM nicotinamide | 2.64 ± 0.18 # | 6.4 ± 0.8 # |
+ 10 µM TPEN | 1.82 ± 0.07 # | 7.2 ± 0.7 # |
+ Zn2+ preload | 0.29 ± 0.03 # | N.P. |
Serum deprivation (6 hr) | 2.01 ± 0.12 * | 7.9 ± 0.3 * |
+ 10 mM pyruvate | 2.45 ± 0.04 # | 5.0 ± 0.4 # |
+ 10 mM nicotinamide | 2.66 ± 0.05 # | 5.2 ± 0.5 # |
+ 10 µM TPEN | 2.62 ± 0.2 # | 6.2 ± 0.2 # |
+ Zn2+ preload | 1.39 ± 0.07 # | N.P. |
indicates a significant difference from control.
indicates a significant difference from toxin alone at P < 0.05 by one-way ANOVA followed by a Bonferroni test.